OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr | ₹-9.08 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-9.59 Cr |
Mar2023 | ₹-7.89 Cr |
Mar2022 | ₹1.50 Cr |
Mar2021 | ₹-1.55 Cr |
Mar2020 | ₹-9.08 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-9.59 Cr | Negative | |
Mar2023 | ₹-7.89 Cr | Negative | |
Mar2022 | ₹1.50 Cr | Positive | |
Mar2021 | ₹-1.55 Cr | Negative | |
Mar2020 | ₹-9.08 Cr | - |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹208.6 Cr | -15.1% | -21.1% | -26.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,329.0 Cr | 0.9% | 3.7% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,991.0 Cr | 7.4% | 9% | 8.2% | Stock Analytics | |
CIPLA | ₹126,326.0 Cr | 3.3% | 0.2% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,126.0 Cr | -0.7% | -1.7% | -0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,324.0 Cr | 1% | -3.2% | -5.2% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -15.1% |
-21.1% |
-26.7% |
SENSEX | 0.7% |
1.1% |
0.9% |
You may also like the below Video Courses